Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
18,515
archived clinical trials in
Lymphoma

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Norris Cotton Cancer Center
mi
from
Lebanon, NH
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Norris Cotton Cancer Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Cooper University Hospital
mi
from
Camden, NJ
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Cooper University Hospital
mi
from
Camden, NJ
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Buffalo
mi
from
Buffalo, NY
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Elmhurst Hospital Center
mi
from
Elmhurst, NY
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Elmhurst Hospital Center
mi
from
Elmhurst, NY
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Queens Cancer Center of Queens Hospital
mi
from
Jamaica, NY
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Queens Cancer Center of Queens Hospital
mi
from
Jamaica, NY
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
North Shore University Hospital
mi
from
Manhasset, NY
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Weill Medical College of Cornell University
mi
from
New York, NY
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Weill Medical College of Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Mount Sinai Medical Center, NY
mi
from
New York, NY
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Mount Sinai Medical Center, NY
mi
from
New York, NY
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Syracuse
mi
from
Syracuse, NY
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Syracuse
mi
from
Syracuse, NY
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
mi
from
Syracuse, NY
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
mi
from
Syracuse, NY
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Asheville
mi
from
Asheville, NC
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Asheville
mi
from
Asheville, NC
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Lineberger Comprehensive Cancer Center, UNC
mi
from
Chapel Hill, NC
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Lineberger Comprehensive Cancer Center, UNC
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Northeast Oncology Associates
mi
from
Concord, NC
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Northeast Oncology Associates
mi
from
Concord, NC
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Durham
mi
from
Durham, NC
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Durham
mi
from
Durham, NC
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Cape Fear Valley Health System
mi
from
Fayetteville, NC
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Cape Fear Valley Health System
mi
from
Fayetteville, NC
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Lenoir Memorial Hospital Cancer Center
mi
from
Kinston, NC
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Lenoir Memorial Hospital Cancer Center
mi
from
Kinston, NC
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
FirstHealth Moore Regional Hospital
mi
from
Pinehurst, NC
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
FirstHealth Moore Regional Hospital
mi
from
Pinehurst, NC
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
New Hanover Regional Medical Center
mi
from
Wilmington, NC
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
New Hanover Regional Medical Center
mi
from
Wilmington, NC
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Winston-Salem, NC
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Comprehensive Cancer Center of Wake Forest University
mi
from
Winston-Salem, NC
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Comprehensive Cancer Center of Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Fargo
mi
from
Fargo, ND
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Fargo
mi
from
Fargo, ND
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Arthur G. James Cancer Hospital - Ohio State University
mi
from
Columbus, OH
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Arthur G. James Cancer Hospital - Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Lifespan: The Miriam Hospital
mi
from
Providence, RI
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Lifespan: The Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Dallas
mi
from
Dallas, TX
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Green Mountain Oncology Group
mi
from
Bennington, VT
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Green Mountain Oncology Group
mi
from
Bennington, VT
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Vermont Cancer Center
mi
from
Burlington, VT
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Vermont Cancer Center
mi
from
Burlington, VT
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - White River Junction
mi
from
White River Junction, VT
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - White River Junction
mi
from
White River Junction, VT
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Martha Jefferson Hospital
mi
from
Charlottesville, VA
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Martha Jefferson Hospital
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Virginia Oncology Associates - Norfolk
mi
from
Norfolk, VA
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Virginia Oncology Associates - Norfolk
mi
from
Norfolk, VA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
MBCCOP - Massey Cancer Center
mi
from
Richmond, VA
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
MBCCOP - Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Oncology and Hematology Associates of Southwest Virginia
mi
from
Roanoke, VA
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Oncology and Hematology Associates of Southwest Virginia
mi
from
Roanoke, VA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
St Mary's Medical Center
mi
from
Huntington, WV
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
St Mary's Medical Center
mi
from
Huntington, WV
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
Ministry Medical Group - Northern Region
mi
from
Rhinelander, WI
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
Ministry Medical Group - Northern Region
mi
from
Rhinelander, WI
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated:  7/7/2015
University of Puerto Rico School of Medicine Medical Sciences Campus
mi
from
San Juan,
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
A Phase I/II Study of Gemcitabine (GEMZAR)/Vinorelbine (NAVELBINE)/Liposomal Doxorubicin (DOXIL) in Relapsed/Refractory Hodgkin's Disease
Status: Enrolling
Updated: 7/7/2015
University of Puerto Rico School of Medicine Medical Sciences Campus
mi
from
San Juan,
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated:  7/7/2015
Northeast Alabama Regional Medical Center
mi
from
Anniston, AL
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated: 7/7/2015
Northeast Alabama Regional Medical Center
mi
from
Anniston, AL
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated:  7/7/2015
Rebecca and John Moores UCSD Cancer Center
mi
from
La Jolla, CA
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated: 7/7/2015
Rebecca and John Moores UCSD Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - San Diego
mi
from
San Diego, CA
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated:  7/7/2015
UCSF Comprehensive Cancer Center
mi
from
San Francisco, CA
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated: 7/7/2015
UCSF Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - San Francisco
mi
from
San Francisco, CA
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated:  7/7/2015
CCOP - Christiana Care Health Services
mi
from
Newark, DE
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated: 7/7/2015
CCOP - Christiana Care Health Services
mi
from
Newark, DE
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated:  7/7/2015
Lombardi Cancer Center
mi
from
Washington,
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated: 7/7/2015
Lombardi Cancer Center
mi
from
Washington,
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated:  7/7/2015
Walter Reed Army Medical Center
mi
from
Washington,
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated: 7/7/2015
Walter Reed Army Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated:  7/7/2015
Veterans Affairs Medical Center - Washington, DC
mi
from
Washington,
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated: 7/7/2015
Veterans Affairs Medical Center - Washington, DC
mi
from
Washington,
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated:  7/7/2015
Broward General Medical Center
mi
from
Fort Lauderdale, FL
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated: 7/7/2015
Broward General Medical Center
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated:  7/7/2015
Memorial Regional Hospital Comprehensive Cancer Center
mi
from
Hollywood, FL
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
A Phase II Study of Sequential Doxorubicin and Topotecan (Dox/Topo) in Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NHL)
Status: Enrolling
Updated: 7/7/2015
Memorial Regional Hospital Comprehensive Cancer Center
mi
from
Hollywood, FL
Click here to add this to my saved trials